logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Financial Reports and Presentations

2025

Årsredovisning 2024

Read more
2024

Årsredovisning 2023

Read more
2024

Annual Report 2023

Read more
2023

Annual Report 2022

Read more
2023

Årsredovisning 2022

Read more
2022

Årsredovisning 2021

Read more
2022

Annual Report 2021

Read more
2021

Årsredovisning 2020

Read more
2021

Annual Report 2020

Read more
2020

Årsredovisning 2019

Read more
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases

IR contact

Viktor Drvota
Viktor Drvota
CEO and Chairman of the Board
[email protected]

Subscribe

CONTACT

Viktor Drvota
CEO and Chairman of the Board
Phone +46 8-524 860 70
[email protected]

All contacts

VISITING ADDRESS

Umecrine Cognition AB
Karolinska Institutet Science Park
Nanna Svartz väg 6A,
171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in Umeå
Reg no 556698-3655

  • Cookies
  • Privacy Policy